{"transactions":[{"id":811331,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-09T21:00:03.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":37985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":40417,"source":{"system":"sec-edgar","filing":"0001213900-26-042050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390026042050/ownership.xml","form_type":"4"}},{"id":1127312,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:01:31.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":138000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."}],"balance_after":138000,"derivative":{"exercise_price":0.688,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0001213900-25-050017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390025050017/ownership.xml","form_type":"4"}},{"id":1341400,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T22:47:13.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing December 5, 2024."}],"balance_after":350000,"derivative":{"exercise_price":1.15,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001213900-24-106119","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390024106119/ownership.xml","form_type":"4"}},{"id":1559294,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T22:06:59.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."}],"balance_after":60000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-24-026712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390024026712/ownership.xml","form_type":"4"}},{"id":1668780,"issuer":{"id":94858,"kind":"organization","name":"LadRx Corp","symbol":"LADX"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-29T16:06:09.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested 50% on the date of grant and the remainder vests in substantially equal installments each month for a period of three (3) years from the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":1.83,"expiration_date":"2034-01-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-004138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/799698/000149315224004138/ownership.xml","form_type":"4"}},{"id":1877752,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T20:36:03.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."}],"balance_after":300000,"derivative":{"exercise_price":0.3025,"exercise_date":"2023-05-23","expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-23-043111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390023043111/ownership.xml","form_type":"4"}},{"id":1877751,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-25T20:36:03.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1520000,"source":{"system":"sec-edgar","filing":"0001213900-23-043111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390023043111/ownership.xml","form_type":"4"}},{"id":2153907,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-20T23:11:07.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":75000,"price":0.4202,"value":31515.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4079 through $0.4230, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1100000,"source":{"system":"sec-edgar","filing":"0001213900-22-057513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390022057513/ownership.xml","form_type":"4"}},{"id":2153906,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-20T23:11:07.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":25000,"price":0.4294,"value":10735.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4196 through $0.4573, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1025000,"source":{"system":"sec-edgar","filing":"0001213900-22-057513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390022057513/ownership.xml","form_type":"4"}},{"id":2176764,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-22T20:42:53.000Z","date":"2022-08-18","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are Restricted Stock Units that vest monthly pro rata over the next 36 months."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001213900-22-050082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390022050082/ownership.xml","form_type":"4"}},{"id":2371533,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option","published_at":"2022-02-25T19:54:37.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."}],"balance_after":6667,"derivative":{"exercise_price":2,"exercise_date":"2022-03-23","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001213900-22-009419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390022009419/ownership.xml","form_type":"4"}},{"id":2480264,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock options","published_at":"2021-12-09T02:23:51.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":130000,"derivative":{"exercise_price":2.77,"exercise_date":"2021-12-07","expiration_date":"2031-12-08","underlying":"Common stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001213900-21-064281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390021064281/ownership.xml","form_type":"4"}},{"id":2525829,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53062,"kind":"person","name":"Claiborne Cary J","position":1,"cik":"0001370930","reported_name":"Claiborne Cary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-11-03T20:35:49.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":60000,"derivative":{"exercise_price":3.15,"exercise_date":"2021-11-02","expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-21-056466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370930/000121390021056466/ownership.xml","form_type":"4"}}]}